Livmoniplimab
Modify Date: 2024-01-09 12:10:57
Livmoniplimab structure
|
Common Name | Livmoniplimab | ||
|---|---|---|---|---|
| CAS Number | 2412004-88-5 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of LivmoniplimabLivmoniplimab (ABBV-151; ARGX-115) is a potent humanized anti-LRRC32 (GARP)/TGFβ1 monoclonal antibody. Livmoniplimab blocks LRRC32-mediated activation of latent TGFβ1. Livmoniplimab has the potential for the research of cancer[1]. |
| Name | Livmoniplimab |
|---|
| Description | Livmoniplimab (ABBV-151; ARGX-115) is a potent humanized anti-LRRC32 (GARP)/TGFβ1 monoclonal antibody. Livmoniplimab blocks LRRC32-mediated activation of latent TGFβ1. Livmoniplimab has the potential for the research of cancer[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |